It's How Medicine Should Be®


French German Italian Portuguese Russian

Obese Adults and a Novel Synbiotic

Clinical Trial Title: 
A study examining the application of a novel synbiotic to modulate the human gut microbiota and improve health in obese adults
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Heather Rasmussen, PhD, RD
Clinical Trial Protocol Description: 

The purpose of this study is to develop a novel dietary strategy by which the human gut microbiota can be successfully modulated to treat obesity and related metabolic disorders. We expect to recruit 180 people for this study. If you are enrolled in the study, you will be compensated for your participation.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are a healthy, clinically obese individual (BMI of 30-40 kg/m2).
  • Are between 18 and 60 years of age.
  • Have no chronic diseases (e.g. heart disease, diabetes).

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Diet and Nutrition
Digestive Disorders
Contact Email: 
Contact Phone: 
(312) 942-3466
Contact Name: 
GI Clinical Trials